Inovio Pharmaceuticals, Inc. (INO)
After hours:
- PR Newswire
INOVIO Reports Financial Results and Highlights for the Second Quarter 2022
INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help protect people from infectious diseases and treat people with cancer and HPV-associated diseases, today reported financial results for the quarter and six months ended June 30, 2022. INOVIO's management will host a live conference call and webcast at 4:30 p.m. Eastern Daylight Time (EDT) today to discuss financial results and provide a general business update for the second quarter. The
- Zacks
Inovio Pharmaceuticals (INO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Inovio (INO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Simply Wall St.
Shareholders in Inovio Pharmaceuticals (NASDAQ:INO) are in the red if they invested a year ago
It's not a secret that every investor will make bad investments, from time to time. But it's not unreasonable to try to...
